Accounts Receivables - Pro Medicus Ltd (ASX:PME) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 113.31 AUD -1.6%

Updated:

Pro Medicus Ltd
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Pro Medicus Ltd
Accounts Receivables Peer Comparison

M7T

4DX

CGS

MEB

MDR

Company		Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Pro Medicus Ltd ASX:PME	Accounts Receivables AU$40.6m	CAGR 3-Years 35%	CAGR 5-Years 20%	CAGR 10-Years 38%
	Mach7 Technologies Ltd ASX:M7T	Accounts Receivables AU$7.9m	CAGR 3-Years 8%	CAGR 5-Years 60%	CAGR 10-Years 75%
	4DMedical Ltd ASX:4DX	Accounts Receivables AU$584.4k	CAGR 3-Years 8%	CAGR 5-Years 29%	CAGR 10-Years N/A
	CogState Ltd ASX:CGS	Accounts Receivables $8.2m	CAGR 3-Years 14%	CAGR 5-Years 12%	CAGR 10-Years 15%
	Medibio Ltd ASX:MEB	Accounts Receivables N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Medadvisor Ltd ASX:MDR	Accounts Receivables AU$8.9m	CAGR 3-Years 29%	CAGR 5-Years 45%	CAGR 10-Years 54%

See Also

Based on the financial report for Dec 31, 2023, Pro Medicus Ltd's Accounts Receivables amounts to 40.6m AUD.

Over the last year, the Accounts Receivables growth was 0%. The average annual Accounts Receivables growth rates for Pro Medicus Ltd have been 35% over the past three years , 20% over the past five years , and 38% over the past ten years .

Join more than 137,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.